Equity Research, Broker Reports, and media content on IPSEN

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about IPSEN
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on IPSEN. We currently have 4 research reports from 1 professional analysts.

Date Source Announcement
10Nov16 01:30 PRN IPSEN to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on November 16th, 2016
10Nov16 01:00 PRN International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2016
26Oct16 02:00 PRN Ipsen Biopharmaceuticals, Inc. Announces Data Presentations at the 2016 Annual Meeting of the Child Neurology Society
19Oct16 01:00 PRN Ipsen Biopharmaceuticals, Inc. Announces Data Presentations at the Annual Meeting of the American Academy of Physical Medicine & Rehabilitation
30Sep16 02:05 PRN Ipsen Biopharmaceuticals, Inc. Announces Nine Poster Presentations at the 2016 North American Neuroendocrine Tumor Society (NANETS) Symposium
21Sep16 06:54 PRN Ipsen Announces Data Presentation for Dysport® (abobotulinumtoxinA) at American Academy of Cerebral Palsy and Developmental Medicine
03Aug16 08:37 PRN Multimedia Assets Now Available: Ipsen Biopharmaceuticals, Inc. announces FDA approval of Dysport® (abobotulinumtoxinA) for the treatment of lower limb spasticity in pediatric patients aged two and older
  • Frequency of research reports

     

  • Research reports on

    IPSEN

  • Providers covering

    IPSEN

Latest Content

View the latest research, videos, and podcasts for this company.